Biosimilars
- Biosimilars – What IBD Patients Should Know
- Biosimilar Patient and Prescriber Outreach Materials
- Biosimilar Development, Review, and Approval
- Biosimilars Basics infographic for Patients
- What is a Biosimilar?
- Prescribing Biosimilar Products
- Biosimilar Development Process
Eosinophilic Esophagitis (EoE)
- ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
- EoE Management Playbook
- Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
- Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
- Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial
- Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis
- Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study
- Proton Pump Inhibitors for Inducing and Maintaining Remission in Eosinophilic Esophagitis: An Updated Systematic Review and Meta-Analysis
- Insights into the natural history and disease course of eosinophilic esophagitis
- Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis
Hepatitis C Virus (HCV)
- AGA Hepatitis C Virus FAQs
- AGA GI Patient Center: Hepatitis C (HCV)
- Direct-Acting Antivirals: Side Effects Management Handouts
- CDC Hepatitis C Resource Center
- U.S. Department of Veterans Affairs: Hepatitis C Resources for Healthcare Professionals and Patients
Hepatitis B Virus (HBV)
- CDC Patient Education Center: Hepatitis B Virus
- CDC Interpretation of Hepatitis B Serologic Test Results
Inflammatory Bowel Disease (IBD)
- AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- ACG Clinical Guideline Update: Ulcerative Colitis in Adults
- ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease
- Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches
- Comparative Efficacy of all Available Pharmaceutical Therapies for Moderate to Severe Crohn’s Disease: A Systematic Review and Network Meta-Analysis
- Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
- Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease
- TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
- Advanced Therapies for Inflammatory Bowel Disease: Navigating Payor and Financial Challenges
- Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?
- AGA IBD Patient Resources
- Resources For Nurses & Advanced Practice Providers: Crohn’s and Colitis Foundation
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Crohn’s and Colitis Foundation Resources for Patients
- Crohn’s & Colitis Foundation. Free educational brochures
- Treatment Approaches in IBD: Shared Decision-Making
- Ostomy Tips and Tricks
- Living with Crohn’s Disease
- Living with Ulcerative Colitis
- CCF IBD Medication Guide
- UIcerative Colitis 101
- Crohn’s 101
